[go: up one dir, main page]

TR200102262T2 - Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. - Google Patents

Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.

Info

Publication number
TR200102262T2
TR200102262T2 TR2001/02262T TR200102262T TR200102262T2 TR 200102262 T2 TR200102262 T2 TR 200102262T2 TR 2001/02262 T TR2001/02262 T TR 2001/02262T TR 200102262 T TR200102262 T TR 200102262T TR 200102262 T2 TR200102262 T2 TR 200102262T2
Authority
TR
Turkey
Prior art keywords
cardiovascular events
preventing
coronary intervention
events related
reducing cardiovascular
Prior art date
Application number
TR2001/02262T
Other languages
English (en)
Inventor
R. Granett Jeffrey
H. Shusterman Neil
C. U'prichard David
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200102262T2 publication Critical patent/TR200102262T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bir memelide özellikle bie insanda koroner müdahale ile ilgili kardiyovasküler olaylarin önlenmesi veya azaltilmasi için, koroner müdahale ile ilgili olarak 300 mg 1100 mg günlük dozda N'(3',4'-dimethoksisinnamoil)anthranilic asid (N-5') veya farmasötik olarak kabul edilir tuzunun verilmesini içeren bir yöntem
TR2001/02262T 1999-02-03 2000-02-02 Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. TR200102262T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11846399P 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
TR200102262T2 true TR200102262T2 (tr) 2002-02-21

Family

ID=22378760

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02262T TR200102262T2 (tr) 1999-02-03 2000-02-02 Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.

Country Status (17)

Country Link
EP (1) EP1180027A4 (tr)
JP (1) JP2002536326A (tr)
KR (1) KR20010101933A (tr)
CN (1) CN1338930A (tr)
AR (1) AR022475A1 (tr)
AU (1) AU2978500A (tr)
BR (1) BR0007901A (tr)
CA (1) CA2361578A1 (tr)
CO (1) CO5160246A1 (tr)
HU (1) HUP0200148A3 (tr)
IL (1) IL144719A0 (tr)
MX (1) MXPA01007833A (tr)
NO (1) NO20013789L (tr)
PL (1) PL349926A1 (tr)
TR (1) TR200102262T2 (tr)
WO (1) WO2000045810A1 (tr)
ZA (1) ZA200106297B (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097650B2 (en) * 2005-07-27 2012-01-17 The Trustees Of Columbia University In The City Of New York Method of treating a condition associated with phosphorylation of TASK-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
AU6837096A (en) * 1995-09-07 1997-03-27 Kissei Pharmaceutical Co. Ltd. 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
NO20013789L (no) 2001-09-28
CO5160246A1 (es) 2002-05-30
IL144719A0 (en) 2002-06-30
MXPA01007833A (es) 2002-06-21
AU2978500A (en) 2000-08-25
KR20010101933A (ko) 2001-11-15
HUP0200148A2 (hu) 2002-05-29
JP2002536326A (ja) 2002-10-29
WO2000045810A1 (en) 2000-08-10
PL349926A1 (en) 2002-10-21
EP1180027A4 (en) 2004-11-17
CA2361578A1 (en) 2000-08-10
HUP0200148A3 (en) 2003-06-30
EP1180027A1 (en) 2002-02-20
CN1338930A (zh) 2002-03-06
NO20013789D0 (no) 2001-08-02
ZA200106297B (en) 2002-07-31
AR022475A1 (es) 2002-09-04
BR0007901A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
EG25822A (en) Quinolinyl-pyrrolopyrazoles
NZ514574A (en) Novel method of treatment
DK1030670T3 (da) Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
DE69738667D1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
DK0998287T3 (da) Anvendelse af levobupivacain
NO20003313L (no) Terapeutiske midler
DK1294379T3 (da) En hidtil ukendt anvendelse af deferipron
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
EE200100066A (et) Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
HUP9903410A2 (hu) Tolfenámsavat vagy gyógyszerészetileg elfogadható sóját tartalmazó, gyors hatóanyag-leadású tabletta
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
PT1058544E (pt) Inibicao da actividade do tnf
GEP20043231B (en) Resorcinol Composition
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
TR200102245T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
JP2002500181A5 (tr)
WO2001042205A3 (en) Treatment of inflammatory bowel disease with vitamin d compounds
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
EP1347754A4 (en) COMPOSITIONS FOR PREVENTION OF ADHESION
MY133957A (en) "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors